Investigation optimal dosing of insulin detemir after switching from other basal insulin by using CGM system

Not Applicable

• Conditions: Diabetes

• Registration Number: JPRN-UMIN000002267
• Lead Sponsor: Tokyo Women's Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-01
• Study Completion: 2010-06-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1.Pregnant, or intention of becoming pregnant. 2.Patients who are judged by investigators as inappropriate subject to participant this trail.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Variability during 24 hours (Sum of difference from average blood glucose level)

Secondary Outcome Measures

Name	Time	Method
-Difference between maximum blood glucose level and minimum blood glucose level (average of 3 days) -Number of hypoglycemia (BG<=50mg/dL) -Number of hyperglycemia (BG>=300mg/dL) -Change of HbA1c -Change of 1.5AG -Over all adverse events -Circumference of waist and hip -Change of height, weight, BMI -Change of insulin dose (total dose, basal dose, bolus dose)